Go to the list of all blogs
Dem Sem's Avatar
published in Blogs
Feb 28, 2025
Medical Companies Segment Shows Strong Performance with +3.53% Weekly Growth

Medical Companies Segment Shows Strong Performance with +3.53% Weekly Growth

The medical companies segment has experienced a notable increase in performance, recording a weekly gain of +3.53%. This sector encompasses companies involved in the production and supply of pharmaceuticals and essential medical products, catering to a broad spectrum of healthcare needs. Their product offerings include surgical apparel, gloves, hospital furniture, fluid management solutions, and specialized equipment for cosmetic and surgical procedures. Key players within this sector include Cardinal Health, Hill-Rom Holdings, and Apyx Medical, each contributing to this segment’s impressive growth trajectory.

Market Capitalization in the Medical Segment

The average market capitalization across this group of medical companies stands at an impressive $26.8 billion. The companies within this segment vary widely in size, with market capitalizations ranging from $2.7 billion to a high of $53.2 billion. Welltower Inc. (WELL) is the largest player in the group, with a valuation of $53.2 billion, while Inari Medical (NARI) has the smallest market cap, standing at $2.7 billion. This diversity in market cap reflects the varying scales of companies in the sector, from large established firms to more specialized, smaller enterprises.

Price Growth Analysis

Over the past week, the average price growth across the segment’s stocks was 3.53%. When observed over a monthly period, the price growth averaged out at 0.7%, while the quarterly price growth demonstrated a more substantial increase of 15.09%. The weekly growth highlights some notable outperformers within the group:

  • Molina Healthcare (MOH): This stock showed an outstanding weekly price growth of +11.79%.
  • Cardinal Health (CAH): CAH also had a positive week, recording a +6.69% increase in price, reaching $103.39.
  • Inari Medical (NARI): NARI experienced a significant price jump of +9.15%, reflecting strong investor interest.

Conversely, Cardinal Health, despite being among the weekly gainers, did have a minimal fall of 0.21% over a longer monthly period, signaling some volatility within the broader uptrend.

Notable Price Movement Announcements

  • August 2, 2024: Cardinal Health (CAH) marked a +6.69% weekly price increase, solidifying its position as a top gainer in the segment.
  • July 26, 2024: Molina Healthcare (MOH) posted an impressive weekly gain of +12.66%, reflecting strong investor confidence.
  • July 2, 2024: Inari Medical (NARI) also achieved a +9.15% weekly gain, further bolstering the overall segment's performance.

Volume Trends in the Medical Segment

Examining volume trends offers additional insight into investor activity within this sector. The average weekly volume growth across the segment declined by -11.53%, indicating some moderation in trading activity. However, this trend changes over a longer timeframe, with the average monthly volume growth surging by 104.57% and quarterly volume growth increasing by 59.5%. This spike in volume over the past quarter suggests heightened investor interest, potentially driven by favorable developments or an optimistic outlook for the sector.

Key Volume Movement Announcements:

  • September 21, 2024: Welltower Inc. (WELL) saw a remarkable single-day volume increase, hitting 215% of its 65-day volume moving average.
  • June 1, 2024: Molina Healthcare (MOH) experienced three consecutive days of elevated trading volume, achieving a peak of 226% above its 65-day volume moving average.
  • March 29, 2024: Inari Medical (NARI) had an impressive surge in trading volume, reaching 824% above its 65-day volume moving average for a single day.

These substantial increases in volume may suggest significant investor actions, such as institutional buys or elevated market interest following major announcements or earnings reports.

Technical Indicators: Positive Momentum and Buy Signals

Several technical indicators suggest potential upward movement in key stocks within the segment, providing signals for potential buying opportunities.

          1. Molina Healthcare (MOH) Breaks Lower Bollinger Band

On October 17, 2024, Molina Healthcare's stock dipped below its lower Bollinger Band, a technical indicator that often signals an upward correction. Historically, in 27 out of 32 instances when MOH's price broke its lower Bollinger Band, the stock price rose in the following month. With an 84% probability of an upward trend, this pattern suggests that MOH may see positive price action soon, potentially making it an attractive candidate for traders considering buying the stock or exploring call options.

          2. Momentum Indicator Turns Positive for Welltower (WELL)

Welltower's Momentum Indicator moved above zero on October 15, 2024, signaling a possible new upward trend. This shift in momentum is typically an early indicator of positive price movement. Analyzing 86 previous instances where this indicator turned positive, the stock rose in 60 cases, giving a 70% likelihood of continued upward movement. Investors may see this as an opportunity to buy WELL shares or purchase call options, riding the potential bullish momentum.

          3. Stochastic Oscillator Signals Potential Decline for Inari Medical (NARI)

On October 18, 2024, the Stochastic Oscillator for Inari Medical moved out of the overbought zone, signaling a possible bearish outlook. Historical data suggests that in 43 out of 54 similar instances, NARI's stock price declined following the exit from the overbought zone, indicating an 80% chance of a downward trend. This technical signal may prompt investors to adopt a defensive stance or consider selling NARI, as there’s a high probability of a short-term pullback.

Summary

The medical companies segment has shown robust performance, with an average weekly price gain of +3.53% and significant quarterly price growth of 15.09%. Companies within this sector, such as Cardinal Health, Molina Healthcare, and Inari Medical, have been at the forefront of this growth, benefiting from strong demand for medical supplies and healthcare services. As investors analyze this sector, they are likely to consider both price and volume trends, along with technical indicators, to identify optimal entry and exit points for these stocks.

Molina Healthcare and Welltower currently exhibit positive momentum signals, suggesting potential buy opportunities, while Inari Medical’s technical indicators signal a possible retracement. With an average market capitalization of $26.8 billion and high trading volumes, this segment presents a dynamic environment for investors looking to gain exposure to the medical supply and healthcare industry.

Related Ticker: NARI, MOH, CAH, WELL

Contributor

Dem Sem's AvatarDem Sem|Expert

View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a medical device company which develops, manufactures, markets and sells devices for the interventional treatment of venous diseases

Industry MedicalSpecialties

Profile
Details
Industry
N/A
Address
6001 Oak Canyon
Phone
+1 877 923-4747
Employees
1300
Web
https://www.inarimedical.com
Interact to see
Advertisement
AngloGold Ashanti (AU) shares are tumbling approximately 11% in premarket trading on March 19, 2026, extending a steep multi-week correction that has now erased more than 35% of the stock's value from its March 2 peak of $129.14. The primary sustained catalyst driving the decline is AngloGold's lowered 2026 production guidance, projecting gold output of 2.80–3.17 million ounces — a mid-point decline versus the company's 2025 output of approximately 3.1 million ounces, and below analyst expectations.
CSIQ shares tumbled approximately 18% in premarket trading on March 19, 2026, following the release of deeply disappointing Q4 2025 earnings before the open. The company reported a net loss of $1.66 per diluted share, far worse than the Wall Street consensus estimate of -$0.98, representing a 69% earnings miss.
YRD shares are tumbling approximately 17% in premarket trading on March 19, 2026, from a prior close of $3.68 to approximately $3.05, following the company's release of Q4 and full-year 2025 financial results before the U.S. market open. Primary catalyst: A dramatic swing to net loss in Q4 2025. Yiren Digital reported a Q4 net loss of RMB 882.2 million (~USD 126.1 million), compared to net income of RMB 331.4 million in Q4 2024 — a more than $250 million deterioration year-over-year.
Shares of MU are down approximately 6.66% in premarket trading on March 19, 2026, sliding from a prior close of $461.73 to around $431.00. Despite a historic earnings beat — fiscal Q2 2026 revenue of $23.86 billion versus the $19.19 billion consensus, and adjusted EPS of $12.20 against an $8.79 estimate — the stock is experiencing a classic "sell the news" reaction.
NEM is trading approximately 9% lower in Thursday premarket, extending Wednesday's 4.56% session loss, as gold prices collapse following the Federal Reserve's hawkish policy hold. Gold spot prices fell 4.21% to $4,616.42 per ounce on March 19, marking the precious metal's sixth straight session of declines — its longest losing streak since late 2024.
Shares of VG are surging approximately +8% in Thursday's premarket session on March 19, 2026, with the stock trading near $16.04, up from the March 18 closing price of $14.85. The primary catalyst is a continuation of bullish momentum driven by a series of analyst price target upgrades, with Scotiabank most recently raising its target from $9 to $11.
LINC shares surged approximately +16% in premarket trading on March 19, 2026, reaching roughly $45.83 from a prior close of $39.51. Primary catalyst: Lincoln Educational Services is hosting its highly anticipated Investor Day today at its brand-new Nashville, TN campus, with presentations beginning at 10:00 am CT (11:00 am ET), live-streamed to investors globally.
PSLV is trading approximately 12% lower in premarket on March 19, 2026, tracking a violent selloff in silver futures. The Federal Reserve's hawkish hold on March 18 — keeping rates at 3.50%–3.75% while signaling fewer cuts ahead — was the primary macro trigger.
The Fed kept rates at 3.5–3.75% and signaled a “higher for longer” stance, with no urgency to cut and a willingness to tighten again if inflation stalls. This backdrop tends to favor quality growth, financials, energy, industrials, and health care, while pressuring long‑duration, leveraged sectors like speculative tech, small caps, utilities, and REITs.
PICS shares fell over 20% today, reversing much of their post‑IPO bounce and dropping well below the US$19 IPO price after initially trading in the mid‑US$15–16 range. The selloff followed PicPay’s Q4 and full‑year 2025 results, which showed strong revenue growth but highlighted thin margins, intense competition and ongoing execution risk in credit underwriting and payments.
RCAT shares fell over 16% today, dropping from recent levels near US$17 toward the mid‑US$14–15 range, after trading as high as US$18.78 in the past year and more than tripling from a 52‑week low of US$4.60.
HYMC shares fell over 13% today, sliding from the mid‑US$30s toward roughly US$31, after trading between US$2.30 and US$58.73 over the past 12 months and closing near US$39 just a few sessions ago.
USAS fell over 10% today, trading around US$5.83 by early afternoon from a previous close of US$6.55 — a one‑day decline of roughly 11% — as more than 5.9 million shares changed hands. The stock had surged earlier in 2026, with some data showing a move from about US$1.11 in March 2025 to over US$7.30 in mid‑March 2026 — a gain of more than 500% — leaving it vulnerable to profit‑taking.
CENX fell about 8.9% today, dropping US$4.94 to US$50.40 by midday, after closing at US$55.34 yesterday; shares now sit roughly 15% below their 52‑week high of US$59.12 but remain far above the 12‑month low of US$13.05. Q4 2025 results showed net sales of US$633.7 million and adjusted net income of US$128.2 million (US$1.25 per share), with adjusted EBITDA of US$170.6 million — a big sequential improvement — but GAAP net income was just US$1.8 million (US$0.02 per share), underscoring earnings volatility.
CNL shares fell over 8% today, trading down from around C$22.90 toward the low‑C$21s, after recently setting a new 1‑year high at C$28.99 on March 2 and gaining more than 70% over the past 12 months.
SMCI shares are plunging approximately 26% in Friday premarket trading, extending sharp after-hours losses from Thursday's session close of $30.79. The primary catalyst is a federal indictment unsealed March 19, 2026, charging three individuals associated with Super Micro — including a company co-founder — with conspiring to illegally export billions of dollars in AI server technology to China.
PL shares are surging approximately 19% in premarket trading on March 20, 2026, building on an 8.67% gain during the regular session on March 19. The primary catalyst is a blowout Q4 fiscal year 2026 earnings report released after the close on March 19, with quarterly revenue of $86.8 million — an 11.55% beat against consensus expectations of $77.81 million.
Unusual Machines (UMAC) is trading down approximately -8.60% in premarket on March 20, 2026, extending losses from the prior session. The primary catalyst is a proposed public stock offering announced after the market close on March 19, 2026, raising dilution concerns among investors.
FDX surged approximately 7% in premarket trading on March 20, 2026, moving from the prior session close of $356.11 to around $381. The primary catalyst is a blowout fiscal Q3 2026 earnings report, with adjusted EPS of $5.25 — beating Wall Street's consensus estimate of $4.13 by more than 27%.
Kingsoft Cloud Holdings Limited (KC) shares plunged about 9% in the most recent session, extending a sharp pullback after a recent rally. The selloff reflects mounting concerns around profitability, with the company still loss-making and showing weak multi-year revenue growth.